
 
 
 
 
 
 
 
 
 The invention claimed is: 
   
 1. A recombinant cell transfected with a nucleic acid encoding an RNA-binding protein containing an RNA recognition motif (RRM) and transfected with a nucleic acid encoding a p180 protein, wherein said transfection provides for enhanced intracellular synthetic or secretory capacity of a protein product of interest,
 wherein the RNA-binding protein containing an RRM is 
 (1) a protein consisting of an amino acid sequence of splicing factor 3B subunit 4 (SF3b4) set forth in SEQ ID NO: 4; 
 (2) a protein consisting of an amino acid sequence with at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 4, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4; or 
 (3) a protein consisting of an amino acid sequence encoded by a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 3, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4. 
 
 
     
 2. The recombinant cell according to  claim 1 , wherein the p180 protein is
 (a) a protein comprising the amino acid sequence set forth in SEQ ID NO: 2; 
 (b) a protein consisting of an amino acid sequence with at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 2, and which has a capability of promoting polysome formation on an intracellular endoplasmic reticulum membrane; or 
 (c) a protein consisting of an amino acid sequence encoded by a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 1, and which has a capability of promoting polysome formation on the intracellular endoplasmic reticulum membrane. 
 
 
     
 3. The recombinant cell according to  claim 1 , wherein the p180 protein is derived from a non-human animal. 
 
     
 4. The recombinant cell according to  claim 3 , wherein the p180 protein is a protein consisting of (i) an amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO: 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 69, 71, 73, 75, 77, 79, 81, 83, 85, or 87; or (ii) an amino acid sequence set forth in SEQ ID NO: 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 64, 65, 66, 67, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, or 88. 
 
     
 5. A recombinant cell comprising an expression unit comprising nucleic acid encoding a protein product of interest and a cis-element recognized by or bound by an RNA-binding protein,
 wherein the cis-element is inserted into the expression unit downstream of a promoter and upstream of a start codon in a nucleotide sequence encoding the protein product of interest, wherein the cis-element comprises two or more motifs consisting of a nucleotide sequence containing 9mer to 12mer sequence of GAN1-(X)n-ACN2, wherein n=3 to 6, N1 and N2 are independently selected from adenine (A), thymine (T), cytosine (C), or guanine (G), and X is selected from adenine (A), thymine (T), cytosine (C), or guanine (G), 
 wherein the recombinant cell is further transfected with a nucleic acid encoding an RNA-binding protein containing an RNA recognition motif (RRM), or transfected with both a nucleic acid encoding a p80 protein and a nucleic acid encoding an RNA-binding protein containing an RRM, wherein said further transfection provides for enhanced intracellular synthetic or secretory capacity of a protein product of interest, and 
 wherein the RNA-binding protein is 
 (1) a protein consisting of an amino acid sequence of splicing factor 3B subunit 4 (SF3b4) set forth in SEQ ID NO: 4; 
 (2) a protein consisting of an amino acid sequence with at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 4, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4; or 
 (3) a protein consisting of an amino acid sequence encoded by a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 3, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4. 
 
 
     
 6. Te recombinant cell according to  claim 5 , wherein the cis-element comprises four of the motifs. 
 
     
 7. A cell line designated by Accession No. NITE BP-01535 (CHO YA7) or Accession No. NITE BP-01811 (CHO 1B2). 
 
     
 8. A method for producing a protein product of interest comprising introducing a nucleic acid molecule encoding the protein product of interest into a recombinant cell transfected with a nucleic acid encoding an RNA-binding protein containing an RNA recognition motif (RRM) er- and transfected with a nucleic acid encoding a p180 protein, whereby the protein product of interest is produced, and production of the protein product of interest is increased due to said transfection,
 wherein the RNA-binding protein containing an RRM is 
 (1) a protein consisting of an amino acid sequence of splicing factor 3B subunit 4 (SF3b4) set forth in SEQ ID NO: 4; 
 (2) a protein consisting of an amino acid sequence with at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 4, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4; or 
 (3) a protein consisting of an amino acid sequence encoded by a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 3, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4. 
 
 
     
 9. The method according to  claim 8 , wherein the p180 protein is
 (a) a protein comprising the amino acid sequence set forth in SEQ ID NO: 2; 
 (b) a protein consisting of an amino acid sequence with at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 2, and which has a capability of promoting polysome formation on an intracellular endoplasmic reticulum membrane; or 
 (c) a protein consisting of an amino acid sequence encoded by a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 1, and which has a capability of promoting polysome formation on the intracellular endoplasmic reticulum membrane. 
 
 
     
 10. The method according to  claim 8 , wherein the p180 protein is derived from a non-human animal. 
 
     
 11. The method according to  claim 10 , wherein the p180 protein is a protein consisting of (i) an amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO: 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 69, 71, 73, 75, 77, 79, 81, 83, 85, or 87; or (ii) an amino acid sequence set forth in SEQ ID NO: 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 64, 65, 66, 67, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, or 88. 
 
     
 12. The method according  claim 8 , wherein the recombinant cell line is designated by Accession No. NITE BP-01535 (CHO YA7) or Accession No. NITE BP-01811 (CHO 1B2). 
 
     
 13. The method according to  claim 8 , wherein the protein product of interest is a glycoprotein. 
 
     
 14. The method according to  claim 13 , wherein the protein product of interest is a collagen, a fibronectin, or an antibody. 
 
     
 15. A method for increasing an amount of a protein product of interest expressed in a cell expression system comprising:
 (a) inserting a cis-element recognized by or interacting with an RNA-binding protein in an expression unit for expressing the protein product of interest, wherein the cis-element is inserted downstream of a promoter and upstream of a start codon in a nucleotide sequence encoding the protein product of interest, whereby the amount of the protein product of interest expressed in the cell expression system is increased, 
 wherein the cis-element comprises two or more motifs consisting of a nucleotide sequence containing 9mer to 12mer sequence of GAN1-(X)n-ACN2, wherein n=3 to 6, N1 and N2 are independently selected from adenine (A), thymine (T), cytosine (C), or guanine (G), and X is selected from adenine (A), thymine (T), cytosine (C), or guanine (G), and 
 (b) expressing the protein of interest in the cell expression system, wherein the cell expression system is a recombinant cell transfected with a nucleic acid encoding an RNA-binding protein containing an RNA recognition motif (RRM), or transfected with both a nucleic acid encoding a p180 protein and a nucleic acid encoding an RNA-binding protein containing an RRM, 
 wherein the RNA-binding protein is 
 (1) a protein consisting of an amino acid sequence of splicing factor 3B subunit 4 (SF3b4) set forth in SEQ ID NO: 4; 
 (2) a protein consisting of an amino acid sequence with at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 4, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4; or 
 (3) a protein consisting of an amino acid sequence encoded by a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 3, and which, when expressed in the cell, has an ability to enhance capacity of the cell for synthesis or secretion of the protein product of interest, wherein the ability is comparable to that of SF3b4 having the amino acid sequence set forth in SEQ ID NO: 4. 
 
 
     
 16. The method according to  claim 15 , wherein the cis-element comprises (i) a nucleotide sequence containing 9mer to 12mer sequence motifs of GAG-(X)n-ACV, wherein n=3 to 6 and V is A, G, or C; and (ii) a nucleotide sequence set forth in one of SEQ ID NOs: 17 to 20. 
 
     
 17. The method according to  claim 15 , wherein the cis-element comprises a sequence selected from the group consisting of: a sequence derived from the nucleotide sequence of the 5′ untranslated region of a type I collagen gene; a sequence derived from the nucleotide sequence of the 5′ untranslated region of a fibronectin gene; a sequence derived from the nucleotide sequence of the 5′ untranslated region of a matrix metalloproteinase 14 (MMP14) gene; and a sequence derived from the nucleotide sequence of the 5′ untranslated region of a prolyl 4-hydroxylase A2 (P4HA2) gene. 
 
     
 18. The method according to  claim 15 , wherein the cis-element comprises SEQ ID NO: 5, or nucleotides at positions 1 to 102, positions 1 to 78, positions 1 to 60, positions 61 to 126, positions 16 to 57, positions 79 to 126, positions 103 to 126, positions 58 to 78, positions 51 to 78, positions 1 to 27, or positions 70 to 78 of SEQ ID NO: 5. 
 
     
 19. The method according to  claim 15 , wherein the cell expression system is a cell having enhanced expression of a SF3b4 protein, or a cell having enhanced expression of both a p180 protein and a SF3b4 protein. 
 
     
 20. The method according to  claim 15 , wherein the cell expression system comprises a cis-element comprising four of the motifs. 
 
   
 
 
 
 
 
 
 
 
